Anzeige
Mehr »
Freitag, 03.07.2026 - Börsentäglich über 12.000 News
Neben Europas Lithium-Gigant: Hebt dieser 8,8-Mio.-Nanocap jetzt ebenfalls ab?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
04.06.Lonza, Stipple Bio Sign ADC Licensing Deal
04.06.Pfizer to Leverage Chai Discovery's AI Platform
04.06.Thermo Fisher Introduces M Series Centrifuges
04.06.Natera, CytoDyn Partner in Colorectal Cancer Study
04.06.Veranova Appoints Dr. Bob Huang as VP & GM of West Deptford, NJ Facility
04.06.SCHOTT Pharma Expands Vial Production in Lebanon, PA
03.06.Ashland Life Sciences Strengthens Presence in Asia Pacific
03.06.Cellares, TScan Partner to Automate Manufacture of TCR-T Candidate
03.06.Lonza Enhances Biologics Preclinical Development Offering
03.06.Lifecore Biomedical Signs Tech Transfer Agreement for Ophthalmic
02.06.West Appoints Michel Lagarde a President and CEO
02.06.Dow, Univar Solutions Sign Agreement to Distribute Low-Carbon Products
02.06.Aragen to Manufacture Renaissance Pharma's Fast Track mAb
02.06.Evotec Appoints Rui Wang as EVP, Head of Global In Silico and AI
01.06.Intravacc, Primrose Bio Renew Partnership Enhancing Conjugate Vaccine Development
01.06.T-CURX Acquires Pantherna Therapeutics to Boost Clinical Validation of In-Vivo CAR-T Therapies
01.06.IL Group Introduces SMCL Series RC-506E Single Minute Changeover Labeler
01.06.Servier Agrees to Acquire Muscular Dystrophy Business of Edgewise Therapeutics
01.06.Ardena Names Dr. Ariane de Ganck as Chief Scientific Officer
01.06.Haisco, Lilly Strike Drug Development Deal
01.06.Circio, GenAssist Partner on AAV Gene Therapy
29.05.Natera, Diakonos Oncology Pair to Test Molecular Response in Refractory Melanoma Patients
29.05.Ratio Therapeutics Expands Manufacturing Collaboration with PharmaLogic
29.05.AstraZeneca's Imfinzi Approved by FDA for BCG-Naïve Non-Muscle-Invasive Bladder Cancer
29.05.Samsung Bioepis Launches OPUVIZ Biosimilar in Europe